Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Eczema | 7% - 12.5% | x | x | |
| Pruritus | 2% - 6% | x | x | |
| Gastrointestinal disorder | 3% | x | ||
| Fungal infection | 3% | x | ||
| Stinging | 2% - 10% | x | x | |
| Dry skin | 2% | x | x | |
| Skin burning sensation | 2% | x | ||
| Redness | 1% | x | ||
| Infection | x | |||
| Rash | x | |||
| Folliculitis | x | x | ||
| Hypertrichosis | x | |||
| Miliaria | x | x | ||
| Telangiectasia | x | |||
| Erythema | x | |||
| Application site reaction | x | |||
| Skin atrophy | x | x | ||
| Growth retardation | x | |||
| Skin irritation | x | |||
| Skin striae | x | x | ||
| Allergic contact dermatitis | x | x | ||
| Leukoderma | x | x | ||
| Acneiform eruption | x | x | ||
| Dermatitis perioral | x | x | ||
| Secondary adrenocortical insufficiency | x | |||
| Atrophy | x | |||
| Rash maculo-papular | x | |||
| Secondary infection | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||
|---|---|---|---|---|
| Dermatitis atopic | x | |||
| Skin disorder | x | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |